Total Liabilities for Insulet (PODD)
According to Insulet's latest reported financial statements, the company's latest reported total liabilities is $1.68B USD. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and net assets for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
PODD
Currently viewingTotal LiabilitiesSwitch metric
Latest period
$1.68B
YoY change
-10.7%
5Y CAGR
+5.7%
Peak year (2024)
$1.88B
Latest annual
$1.68B
Total Liabilities history chart for Insulet (PODD) from 2002 to 2025
Total Liabilities history table for Insulet (PODD) from 2002 to 2025
| Fiscal year | Period ended | Reported | Total Liabilities | YoY |
|---|---|---|---|---|
| 2025 | $1.68B | -10.7% | ||
| 2024 | $1.88B | +1.1% | ||
| 2023 | $1.86B | +4.6% | ||
| 2022 | $1.77B | +18.9% | ||
| 2021 | $1.49B | +17.6% | ||
| 2020 | $1.27B | +19.0% | ||
| 2019 | $1.07B | +48.9% | ||
| 2018 | $716.64M | +8.9% | ||
| 2017 | $658.23M | +67.3% | ||
| 2016 | $393.50M | +63.2% | ||
| 2015 | $241.07M | +10.4% | ||
| 2014 | $218.33M | +33.6% | ||
| 2013 | $163.36M | +6.2% | ||
| 2012 | $153.88M | +11.4% | ||
| 2011 | $138.19M | +53.5% | ||
| 2010 | $90.00M | -24.2% | ||
| 2009 | $118.79M | +13.2% | ||
| 2008 | $104.95M | +172.9% | ||
| 2007 | $38.47M | -75.8% | ||
| 2006 | $158.91M | +91.7% | ||
| 2005 | $82.88M | +15.7% | ||
| 2004 | $71.63M | +101.2% | ||
| 2003 | $35.61M | -1.5% | ||
| 2002 | $36.16M | — |
Total Liabilities values are taken from Insulet's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Insulet (PODD) total liabilities totalled $1.68B – declined 10.7% year-over-year.
Across 2020–2025 (5 years), Insulet total liabilities produced a CAGR of +5.7% – with the latest reading among the more recent periods of the dataset.
The highest annual total liabilities of $1.88B was reported in 2024. The lowest in the available history was $35.61M in 2003.
Within Healthcare, Insulet (PODD) ranks 9th among 8 peers we track. The peer median for total liabilities is $101.80B.
Insulet Total Liabilities by Year
Insulet Total Liabilities 2025: $1.68B
Insulet total liabilities in 2025 was $1.68B, declined 10.7% below 2024.
Insulet Total Liabilities 2024: $1.88B
Insulet total liabilities in 2024 was $1.88B, edged up 1.1% from 2023. This figure represents the highest annual value in the available history.
Insulet Total Liabilities 2023: $1.86B
Insulet total liabilities in 2023 was $1.86B, edged up 4.6% from 2022.
Insulet Total Liabilities 2022: $1.77B
Insulet total liabilities in 2022 was $1.77B, grew 18.9% from 2021.
Insulet Total Liabilities 2021: $1.49B
Insulet total liabilities in 2021 was $1.49B.
See more financial history for Insulet (PODD).
Sector peers — Total Liabilities
Companies in the same sector as Insulet, ranked by their latest total liabilities.
| Company | Total Liabilities | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $348.86B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $207.88B | Healthcare |
| AbbVie Inc. (ABBV) | $137.19B | Healthcare |
| Johnson & Johnson (JNJ) | $117.67B | Healthcare |
| Eli Lilly and Company (LLY) | $85.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $84.20B | Healthcare |
| Amgen Inc. (AMGN) | $81.93B | Healthcare |
| AstraZeneca PLC (AZN) | $65.36B | Healthcare |
Frequently asked questions
What is Insulet's total liabilities?
- Latest reported total liabilities for Insulet (PODD) is $1.68B (period ending December 31, 2025).
How has Insulet total liabilities changed year-over-year?
- Insulet (PODD) total liabilities changed -10.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Insulet total liabilities?
- Insulet (PODD) total liabilities compound annual growth rate is +5.7% over the most recent 5 years available.
When did Insulet total liabilities hit its highest annual value?
- Insulet total liabilities reached its highest annual value of $1.88B in 2024.
What was Insulet total liabilities in 2024?
- Insulet (PODD) total liabilities in 2024 was $1.88B.
What was Insulet total liabilities in 2025?
- Insulet (PODD) total liabilities in 2025 was $1.68B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
PODD Overview
Company profile, financial tools, and key metrics
PODD Revenue Counter
Earns $85.88 every second. See per minute, hour, and day.
PODD Earnings Counter
Earns $7.84 per second net profit. See per minute, hour, and day.
PODD Economic Scale
Exceeds St. Lucia's GDP. Compare with world economies.
PODD What If Invested
What if you had invested $1,000? See historical returns from any date.
PODD How It Makes Money
Discover visual breakdown of $2.71B in revenue — where it comes from and where it goes.
PODD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
PODD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
PODD Daily Price Character
Explosive · 51.5% historical win rate (green days). Streaks & record days.
PODD Buybacks
0.30% TTM buyback yield. Shareholder yield & SBC comparison.